Company: TVRD
Filing Date: 2025-10-07
Form Type: S-1/A
Source: 0001104659-25-097519
Chunk: 370

Company: Tvardi Therapeutics, Inc.
Filing Date: 2025-10-07
Form: S-1/A
Chunk 370
---
, Ltd. and Baylor College of Medicine, dated June 19, 2015, subject to Notice of Assignment from Stem Med Limited Partnership to Tvardi Therapeutics, Inc. dated February 22, 2018, and as amended on June 18, 2019 and April 6, 2023 (incorporated by reference from Exhibit 10.33 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                     |
| ​     | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.5

# | ​ | Offer Letter by and between Imran Alibhai, Ph.D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.27 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                                  |
| ​     | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.6

# | ​ | Offer Letter by and between Dan Conn and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.28 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                                              |
| ​     | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.7

# | ​ | Offer Letter by and between John Kauh, M.D. and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.29 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                                       |
| ​     | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 10.8

# | ​ | Offer Letter by and between Jeffrey Larson, Ph.D., DABT and Tvardi Therapeutics, Inc. (incorporated by reference from Exhibit 10.30 to the Registrant’s Registration Statement on Form S-4 (File No. 333-283900), filed with the SEC on December 18, 2024).                                                                                                                                                                                                                                                           |
| ​     | ​ | ​                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |

II-3

|